Muse bio secures $23M Series B financing led by Venrock

Muse bio, a privately-held company leading the development of next-generation genome engineering capabilities, today announced the completion of a $23 million Series B financing. The oversubscribed financing was led by Venrock and included investments from Foresite Capital and Paladin Capital as well as both Series A investors, NanoDimension and Spruce/MLS.

PhishMe Reports Explosive Growth: Annual Run Rate Approaches $50 Million

PhishMe Inc., the leading provider of human phishing defense solutions, today announced another year of record growth, with Annual Run Rate (ARR) approaching $50 million. PhishMe’s more than 300 employees now serve 1,200 enterprise customers world-wide to defend against cybercriminals, hacktivists and state-sponsored hackers.

Paladin SAG Member Jeremy Bash on US-Russian Relations

Jeremy Bash, a member of Paladin Capital Group’s Strategic Advisory Group, made a number of recent media appearances on Russian cyber attacks against the United States and the current state of the U.S. Intelligence Community. The evening of January 4, 2017, he...

Paladin Year in Review 2017

Friends of Paladin:   With 2017 now underway, we want to share with you our Annual Cyber Year in Review. 2016 was another watershed year for cybersecurity, with several key trends to highlight as well as new themes likely to emerge as we move into 2017.  ...

Page 1 of 1912345...10...Last »